1. Home
  2. GKOS vs HR Comparison

GKOS vs HR Comparison

Compare GKOS & HR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • HR
  • Stock Information
  • Founded
  • GKOS 1998
  • HR 1992
  • Country
  • GKOS United States
  • HR United States
  • Employees
  • GKOS N/A
  • HR N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • HR Real Estate Investment Trusts
  • Sector
  • GKOS Health Care
  • HR Real Estate
  • Exchange
  • GKOS Nasdaq
  • HR Nasdaq
  • Market Cap
  • GKOS 5.8B
  • HR 5.3B
  • IPO Year
  • GKOS 2015
  • HR 1993
  • Fundamental
  • Price
  • GKOS $89.83
  • HR $16.46
  • Analyst Decision
  • GKOS Strong Buy
  • HR Hold
  • Analyst Count
  • GKOS 12
  • HR 5
  • Target Price
  • GKOS $131.17
  • HR $16.40
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • HR 3.5M
  • Earning Date
  • GKOS 07-30-2025
  • HR 07-31-2025
  • Dividend Yield
  • GKOS N/A
  • HR 5.85%
  • EPS Growth
  • GKOS N/A
  • HR N/A
  • EPS
  • GKOS N/A
  • HR N/A
  • Revenue
  • GKOS $432,953,000.00
  • HR $1,222,259,000.00
  • Revenue This Year
  • GKOS $27.88
  • HR N/A
  • Revenue Next Year
  • GKOS $27.76
  • HR $1.90
  • P/E Ratio
  • GKOS N/A
  • HR N/A
  • Revenue Growth
  • GKOS 26.70
  • HR N/A
  • 52 Week Low
  • GKOS $77.10
  • HR $14.09
  • 52 Week High
  • GKOS $163.71
  • HR $18.90
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • HR 53.35
  • Support Level
  • GKOS $88.94
  • HR $15.29
  • Resistance Level
  • GKOS $92.70
  • HR $17.07
  • Average True Range (ATR)
  • GKOS 3.82
  • HR 0.38
  • MACD
  • GKOS 0.38
  • HR -0.03
  • Stochastic Oscillator
  • GKOS 46.71
  • HR 65.73

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About HR Healthcare Realty Trust Incorporated

Healthcare Realty Trust Inc is a healthcare facility real estate investment trust. The company focuses on owning, leasing, and managing outpatient facilities and other healthcare properties. The company works to invest in outpatient facilities that are integral to a hospital's operations. It generates all of its revenue in the United States.

Share on Social Networks: